167 related articles for article (PubMed ID: 26496175)
41. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
[TBL] [Abstract][Full Text] [Related]
42. Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region.
Yu JW; Jeffrey PD; Ha JY; Yang X; Shi Y
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21004-9. PubMed ID: 22158899
[TBL] [Abstract][Full Text] [Related]
43. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors.
Wu G; Wang H; Zhou W; Zeng B; Mo W; Zhu K; Liu R; Zhou J; Chen C; Chen H
Bioorg Med Chem; 2018 Jul; 26(12):3321-3344. PubMed ID: 29751989
[TBL] [Abstract][Full Text] [Related]
45. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
47. GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.
Cheng J; Klei LR; Hubel NE; Zhang M; Schairer R; Maurer LM; Klei HB; Kang H; Concel VJ; Delekta PC; Dang EV; Mintz MA; Baens M; Cyster JG; Parameswaran N; Thome M; Lucas PC; McAllister-Lucas LM
J Clin Invest; 2020 Feb; 130(2):1036-1051. PubMed ID: 31961340
[TBL] [Abstract][Full Text] [Related]
48. Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease.
Lu T; Connolly PJ; Philippar U; Sun W; Cummings MD; Barbay K; Gys L; Van Nuffel L; Austin N; Bekkers M; Shen F; Cai A; Attar R; Meerpoel L; Edwards J
Bioorg Med Chem Lett; 2019 Dec; 29(23):126743. PubMed ID: 31678006
[TBL] [Abstract][Full Text] [Related]
49. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.
Jin Z; Qing K; Ouyang Y; Liu Z; Wang W; Li X; Xu Z; Li J
J Exp Clin Cancer Res; 2016 Mar; 35():52. PubMed ID: 27009084
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
51. [Detection of API2-MALT1 fusion gene in extranodal B-cell lymphoma and its significance].
Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):92-6. PubMed ID: 16630483
[TBL] [Abstract][Full Text] [Related]
52. Mechanism and specificity of the human paracaspase MALT1.
Hachmann J; Snipas SJ; van Raam BJ; Cancino EM; Houlihan EJ; Poreba M; Kasperkiewicz P; Drag M; Salvesen GS
Biochem J; 2012 Apr; 443(1):287-95. PubMed ID: 22309193
[TBL] [Abstract][Full Text] [Related]
53. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
54. Chemical Probes for Profiling of MALT1 Protease Activity.
Verhelst SHL; Prothiwa M
Chembiochem; 2023 Nov; 24(21):e202300444. PubMed ID: 37607867
[TBL] [Abstract][Full Text] [Related]
55. Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease.
Asaba KN; Adachi Y; Tokumaru K; Watanabe A; Goto Y; Aoki T
Bioorg Med Chem Lett; 2021 Jun; 41():127996. PubMed ID: 33775836
[TBL] [Abstract][Full Text] [Related]
56. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
57. MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies.
Liang X; Cao Y; Li C; Yu H; Yang C; Liu H
Med Res Rev; 2021 Jul; 41(4):2388-2422. PubMed ID: 33763890
[TBL] [Abstract][Full Text] [Related]
58. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.
Staal J; Driege Y; Bekaert T; Demeyer A; Muyllaert D; Van Damme P; Gevaert K; Beyaert R
EMBO J; 2011 May; 30(9):1742-52. PubMed ID: 21448133
[TBL] [Abstract][Full Text] [Related]
59. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.
Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S
J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426
[TBL] [Abstract][Full Text] [Related]
60. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
